Header Logo

Connection

Kyle Amber to Humans

Back to Details
This is a "connection" page, showing publications Kyle Amber has written about Humans.
Kyle Amber
Connection Strength
2.542
Humans
  1. Targeting interleukin (IL)-4/IL-13 in immune checkpoint inhibitor-induced bullous pemphigoid: a cautionary note on the beneficial effect of T helper 2 immunity in melanoma and immunotherapy. Br J Dermatol. 2023 Dec 20; 190(1):137-138.
    View in: PubMed
    Score: 0.052
  2. C-type lectin receptor expression is a hallmark of neutrophils infiltrating the skin in epidermolysis bullosa acquisita. Front Immunol. 2023; 14:1266359.
    View in: PubMed
    Score: 0.051
  3. Two patients with concomitant bullous pemphigoid and psoriasis successfully treated by IL-23 inhibition. J Eur Acad Dermatol Venereol. 2023 11; 37(11):e1339-e1340.
    View in: PubMed
    Score: 0.050
  4. Atrophic pink-to-yellow papules on the left lower leg. J Dtsch Dermatol Ges. 2023 07; 21(7):810-811.
    View in: PubMed
    Score: 0.050
  5. Diversity in autoimmune blistering disease clinical trials: a systematic review. Int J Dermatol. 2023 10; 62(10):e561-e562.
    View in: PubMed
    Score: 0.049
  6. Insights Into the Pathogenesis of Bullous Pemphigoid: The Role of Complement-Independent Mechanisms. Front Immunol. 2022; 13:912876.
    View in: PubMed
    Score: 0.047
  7. Development of Pneumocystis pneumonia in a patient receiving both rituximab and IVIg for pemphigus vulgaris. J Dtsch Dermatol Ges. 2022 04; 20(4):520-521.
    View in: PubMed
    Score: 0.046
  8. The Immunogenetics of Autoimmune Blistering Diseases. Adv Exp Med Biol. 2022; 1367:173-212.
    View in: PubMed
    Score: 0.045
  9. Palbociclib-induced IgA vasculitis. Dermatol Online J. 2021 12 15; 27(12).
    View in: PubMed
    Score: 0.045
  10. Gene expression profiling of laminin a3-blocked keratinocytes reveals an immune-independent mechanism of blistering. Exp Dermatol. 2022 04; 31(4):615-621.
    View in: PubMed
    Score: 0.045
  11. Subunit-Specific Reactivity of Autoantibodies Against Laminin-332 Reveals Direct Inflammatory Mechanisms on Keratinocytes. Front Immunol. 2021; 12:775412.
    View in: PubMed
    Score: 0.045
  12. The risk of Pneumocystis pneumonia in patients of?autoimmune blistering disease-reply to letter entitled "Pemphigus management guidelines: A life-saving perspective". J Am Acad Dermatol. 2021 11; 85(5):e289.
    View in: PubMed
    Score: 0.044
  13. Characterizing the proteome of bullous pemphigoid blister fluid utilizing tandem mass tag labeling coupled with LC-MS/MS. Arch Dermatol Res. 2022 Nov; 314(9):921-928.
    View in: PubMed
    Score: 0.044
  14. Inhibition of dipeptidyl-peptidase 4 induces upregulation of the late cornified envelope cluster in keratinocytes. Arch Dermatol Res. 2022 Nov; 314(9):909-915.
    View in: PubMed
    Score: 0.043
  15. Disease-dependent Risk of Pneumocystis Pneumonia: The Case of Autoimmune Blistering Disease. Chest. 2020 12; 158(6):2704-2705.
    View in: PubMed
    Score: 0.042
  16. The role of Dipeptidyl Peptidase-4 in cutaneous disease. Exp Dermatol. 2021 03; 30(3):304-318.
    View in: PubMed
    Score: 0.042
  17. Autoreactive T cells in pemphigus: perpetrator and target. Ital J Dermatol Venerol. 2021 04; 156(2):124-133.
    View in: PubMed
    Score: 0.042
  18. Pemphigus vulgaris manifesting as severe oral and epiglottal epithelial dysplasia. J Dtsch Dermatol Ges. 2020 Aug; 18(8):895-896.
    View in: PubMed
    Score: 0.041
  19. A Review Comparing International Guidelines for the Management of Bullous Pemphigoid, Pemphigoid Gestationis, Mucous Membrane Pemphigoid, and Epidermolysis Bullosa Acquisita. Am J Clin Dermatol. 2020 Aug; 21(4):557-565.
    View in: PubMed
    Score: 0.041
  20. Eosinophils in bullous pemphigoid. Panminerva Med. 2021 Sep; 63(3):368-378.
    View in: PubMed
    Score: 0.041
  21. Digital Quantification of Epidermal Protein Expression in Paraffin-Embedded Tissue Using Immunohistochemistry. Methods Mol Biol. 2020; 2109:75-82.
    View in: PubMed
    Score: 0.039
  22. IgA pemphigus: A systematic review. J Am Acad Dermatol. 2020 Jun; 82(6):1386-1392.
    View in: PubMed
    Score: 0.039
  23. Autoimmune blistering diseases provoked during the treatment of chronic inflammatory disease with biologic agents: a systematic review. Int J Dermatol. 2020 May; 59(5):520-524.
    View in: PubMed
    Score: 0.039
  24. Epidermal expression of eotaxins and thymic stromal lymphopoietin in eosinophil rich dermatoses. Arch Dermatol Res. 2019 Nov; 311(9):705-710.
    View in: PubMed
    Score: 0.038
  25. Epidermolysis bullosa acquisita: A comprehensive review. Autoimmun Rev. 2019 Aug; 18(8):786-795.
    View in: PubMed
    Score: 0.038
  26. Pemphigus subtype: a confounder in determining the association of oral involvement with post-rituximab relapses. Dermatol Ther. 2019 05; 32(3):e12918.
    View in: PubMed
    Score: 0.038
  27. Dapsone, 2 birds with 1 stone: A response to "Dapsone advantages over trimethoprim-sulfamethoxazole for Pneumocystis pneumonia prophylaxis in immunobullous patients". J Am Acad Dermatol. 2021 12; 85(6):e369.
    View in: PubMed
    Score: 0.037
  28. Comment on "Incidence of pneumocystosis among patients exposed to immunosuppression". J Am Acad Dermatol. 2019 08; 81(2):e47.
    View in: PubMed
    Score: 0.037
  29. Serum and blister fluid levels of cytokines and chemokines in pemphigus and bullous pemphigoid. Autoimmun Rev. 2019 May; 18(5):526-534.
    View in: PubMed
    Score: 0.037
  30. Mechanisms of pathogenic effects of eosinophil cationic protein and eosinophil-derived neurotoxin on human keratinocytes. Exp Dermatol. 2018 12; 27(12):1322-1327.
    View in: PubMed
    Score: 0.036
  31. Targeted Therapies for Autoimmune Bullous Diseases: Current Status. Drugs. 2018 Oct; 78(15):1527-1548.
    View in: PubMed
    Score: 0.036
  32. Gastrointestinal prophylaxis in patients with autoimmune blistering disease treated with corticosteroids: an expert survey. Int J Dermatol. 2018 11; 57(11):e125-e126.
    View in: PubMed
    Score: 0.036
  33. Paraneoplastic autoimmune multiorgan syndrome (PAMS): Beyond the single phenotype of paraneoplastic pemphigus. Autoimmun Rev. 2018 Oct; 17(10):1002-1010.
    View in: PubMed
    Score: 0.036
  34. Underlying Systemic Diseases in Pyoderma Gangrenosum: A Systematic Review and Meta-Analysis. Am J Clin Dermatol. 2018 Aug; 19(4):479-487.
    View in: PubMed
    Score: 0.036
  35. Non-Desmoglein Antibodies in Patients With Pemphigus Vulgaris. Front Immunol. 2018; 9:1190.
    View in: PubMed
    Score: 0.035
  36. A case of photodistributed multicentric reticulohistiocytosis: correlation with multiphoton microscopy imaging. J Dtsch Dermatol Ges. 2018 Jun; 16(6):781-783.
    View in: PubMed
    Score: 0.035
  37. Paraneoplastic autoimmune multi-organ syndrome is a distinct entity from traditional pemphigus subtypes. Nat Rev Dis Primers. 2018 02 22; 4:18012.
    View in: PubMed
    Score: 0.035
  38. Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management. Clin Rev Allergy Immunol. 2018 Feb; 54(1):26-51.
    View in: PubMed
    Score: 0.034
  39. Localized pretibial bullous pemphigoid arising in a patient on pembrolizumab for metastatic melanoma. J Dtsch Dermatol Ges. 2018 Feb; 16(2):196-198.
    View in: PubMed
    Score: 0.034
  40. Coverage of Intravenous Immunoglobulin for Autoimmune Blistering Diseases Among US Insurers. JAMA Dermatol. 2017 11 01; 153(11):1189-1190.
    View in: PubMed
    Score: 0.034
  41. Determining the Incidence of Pneumocystis Pneumonia in Patients With Autoimmune Blistering Diseases Not Receiving Routine Prophylaxis. JAMA Dermatol. 2017 11 01; 153(11):1137-1141.
    View in: PubMed
    Score: 0.034
  42. Second primary cutaneous T-cell lymphoma in patients with non-Hodgkin lymphoma: a chicken-or-the-egg issue. Int J Dermatol. 2018 01; 57(1):113.
    View in: PubMed
    Score: 0.034
  43. A case report of bullous pemphigoid associated with a melanoma and review of the literature. Melanoma Res. 2017 02; 27(1):65-67.
    View in: PubMed
    Score: 0.032
  44. Identifying the incidence of rash, Stevens-Johnson syndrome and toxic epidermal necrolysis in patients taking lamotrigine: a systematic review of 122 randomized controlled trials. An Bras Dermatol. 2017 Jan-Feb; 92(1):139-141.
    View in: PubMed
    Score: 0.032
  45. Balancing the risks and benefits of prophylaxis: a reply to "Pneumocystis jiroveci pneumonia in patients treated with systemic immunosuppressive agents for dermatologic conditions". Int J Dermatol. 2017 01; 56(1):e4-e5.
    View in: PubMed
    Score: 0.031
  46. The controversy of hepatitis C and rituximab: A multidisciplinary dilemma with implications for patients with pemphigus. Indian J Dermatol Venereol Leprol. 2016 Mar-Apr; 82(2):182-3.
    View in: PubMed
    Score: 0.030
  47. Second Primary Malignancies in CTCL Patients from 1992 to 2011: A SEER-Based, Population-Based Study Evaluating Time from CTCL Diagnosis, Age, Sex, Stage, and CD30+ Subtype. Am J Clin Dermatol. 2016 Feb; 17(1):71-7.
    View in: PubMed
    Score: 0.030
  48. Association of Google Search Volume Index Peaks for Skin Cancer With Skin Cancer Awareness Month--Reply. JAMA Dermatol. 2016 Jan; 152(1):113-4.
    View in: PubMed
    Score: 0.030
  49. Granulomatosis with polyangiitis (GPA) initially presenting as sigmoiditis with the later development of spontaneous subcapsular hematoma. Int J Colorectal Dis. 2016 Jul; 31(7):1365-6.
    View in: PubMed
    Score: 0.030
  50. Is anti-BP180 IgE associated with clinical phenotype? A reply to 'Levels of anti-BP180 NC16A IgE do not correlate with severity of disease in the early stages of bullous pemphigoid'. Arch Dermatol Res. 2016 Jan; 308(1):65-6.
    View in: PubMed
    Score: 0.030
  51. Topical antioxidants in radiodermatitis: a clinical review. Int J Palliat Nurs. 2015 Sep; 21(9):446-52.
    View in: PubMed
    Score: 0.029
  52. Thrombotic thrombocytopenic purpura in a postoperative patient taking cephalexin responding to plasmapheresis: A case report and review of cephalosporin-induced TTP. J Clin Apher. 2016 Oct; 31(5):473-5.
    View in: PubMed
    Score: 0.029
  53. Private and public coverage policies for rituximab in the treatment of immunobullous disease in the United States. J Am Acad Dermatol. 2015 Aug; 73(2):337-8.
    View in: PubMed
    Score: 0.029
  54. A Systematic Review of Patients with Mucocutaneous and Respiratory Complications in Paraneoplastic Autoimmune Multiorgan Syndrome: Castleman's Disease is the Predominant Malignancy. Lung. 2015 Aug; 193(4):593-6.
    View in: PubMed
    Score: 0.028
  55. Visual identification of skin cancer in beachgoers: a need for improved education on non-melanoma skin cancer in the general population and melanoma in the African-American population. Int J Dermatol. 2015 Mar; 54(3):e85-7.
    View in: PubMed
    Score: 0.028
  56. Comparing the accuracy of ultrasound versus fluoroscopy in glenohumeral injections: a systematic review and meta-analysis. J Clin Ultrasound. 2014 Sep; 42(7):411-6.
    View in: PubMed
    Score: 0.026
  57. Blue skin. Int J Dermatol. 2014 Mar; 53(3):275-6.
    View in: PubMed
    Score: 0.026
  58. Conflict of interest in online point-of-care clinical support websites. J Med Ethics. 2014 Aug; 40(8):578-80.
    View in: PubMed
    Score: 0.026
  59. If students cannot deliver bad news, they should not be the first to see patients awaiting bad news. Acad Med. 2014 Jan; 89(1):9.
    View in: PubMed
    Score: 0.026
  60. Does improved confidence in a disease relate to increased knowledge? Our experience with medical students. Pain Med. 2014 Mar; 15(3):483-4.
    View in: PubMed
    Score: 0.026
  61. Pharmaceutical ethics and physician liability in Side Effects. J Med Humanit. 2013 Dec; 34(4):497-503.
    View in: PubMed
    Score: 0.026
  62. Autoreactive T cells in the immune pathogenesis of pemphigus vulgaris. Exp Dermatol. 2013 Nov; 22(11):699-704.
    View in: PubMed
    Score: 0.026
  63. Artist's statement: The Sight of Sickness. Acad Med. 2013 Aug; 88(8):1080.
    View in: PubMed
    Score: 0.025
  64. The use of antioxidants in radiotherapy-induced skin toxicity. Integr Cancer Ther. 2014 Jan; 13(1):38-45.
    View in: PubMed
    Score: 0.025
  65. Direct to consumer advertising's effect on medical students: the case of fibromyalgia. Med Teach. 2013 Nov; 35(11):969-70.
    View in: PubMed
    Score: 0.025
  66. The Merkel cell polyomavirus and its involvement in Merkel cell carcinoma. Dermatol Surg. 2013 Feb; 39(2):232-8.
    View in: PubMed
    Score: 0.024
  67. Prophylactic valacyclovir in a patient with recurrent vestibular disturbances secondary to vestibular neuritis. Am J Otolaryngol. 2012 Jul-Aug; 33(4):487-8.
    View in: PubMed
    Score: 0.022
  68. SuPAR mediates viral response proteinuria by rapidly changing podocyte function. Nat Commun. 2023 07 21; 14(1):4414.
    View in: PubMed
    Score: 0.013
  69. Risk of infections in patients with pemphigus treated with rituximab vs. azathioprine or mycophenolate mofetil: a large-scale global cohort study. Br J Dermatol. 2023 03 30; 188(4):499-505.
    View in: PubMed
    Score: 0.012
  70. Melanoma is associated with an increased risk of bullous pemphigoid: a large population-based longitudinal study. Arch Dermatol Res. 2022 Jan; 314(1):77-83.
    View in: PubMed
    Score: 0.011
  71. Dysregulated microRNA expression in IL-4 transgenic mice, an animal model of atopic dermatitis. Arch Dermatol Res. 2021 Dec; 313(10):837-846.
    View in: PubMed
    Score: 0.011
  72. Patients with pemphigus are at an increased risk of developing rheumatoid arthritis: a large-scale cohort study. Immunol Res. 2020 12; 68(6):373-378.
    View in: PubMed
    Score: 0.010
  73. Hidradenitis suppurativa is associated with acne keloidalis nuchae: a population-based study. Arch Dermatol Res. 2021 Jul; 313(5):333-337.
    View in: PubMed
    Score: 0.010
  74. Hidradenitis suppurativa and pemphigus: a cross-sectional study. Arch Dermatol Res. 2020 Sep; 312(7):501-505.
    View in: PubMed
    Score: 0.010
  75. The Risk of Pulmonary Embolism in Patients With Pemphigus: A Population-Based Large-Scale Longitudinal Study. Front Immunol. 2019; 10:1559.
    View in: PubMed
    Score: 0.010
  76. Synergy among non-desmoglein antibodies contributes to the immunopathology of desmoglein antibody-negative pemphigus vulgaris. J Biol Chem. 2019 03 22; 294(12):4520-4528.
    View in: PubMed
    Score: 0.009
  77. Is there an association between dipeptidyl peptidase-4 inhibitors and autoimmune disease? A population-based study. Immunol Res. 2018 06; 66(3):425-430.
    View in: PubMed
    Score: 0.009
  78. Syringotropic Mycosis Fungoides: A Rare Form of Cutaneous T-cell Lymphoma Enabling a Histopathologic "Sigh of Relief". Am J Dermatopathol. 2017 Dec; 39(12):920-923.
    View in: PubMed
    Score: 0.009
  79. Rituximab as first-line adjuvant therapy for pemphigus: Retrospective analysis of long-term outcomes at a single center. J Am Acad Dermatol. 2018 04; 78(4):806-808.
    View in: PubMed
    Score: 0.008
  80. Immune response in pemphigus and beyond: progresses and emerging concepts. Semin Immunopathol. 2016 Jan; 38(1):57-74.
    View in: PubMed
    Score: 0.007
  81. Google Search Trends and Skin Cancer: Evaluating the US Population's Interest in Skin Cancer and Its Association With Melanoma Outcomes. JAMA Dermatol. 2015 Aug; 151(8):903-5.
    View in: PubMed
    Score: 0.007
  82. An increased risk of non-Hodgkin lymphoma and chronic lymphocytic leukemia in US patients with Merkel cell carcinoma versus Australian patients: A clinical clue to a different mechanism of pathogenesis? Australas J Dermatol. 2016 Aug; 57(3):e114-6.
    View in: PubMed
    Score: 0.007
  83. A schwannoma of the greater petrosal nerve located within the petrous apex and treated with stereotactic radiotherapy. Am J Otolaryngol. 2013 Sep-Oct; 34(5):596-9.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.